Jaana Ahlamaa established Medaffcon in 2009 to serve the needs of the pharmaceutical industry. Already the following year, Jarmo Hahl and Tatu Miettinen joined the team of owners, as the triplet realised the opportunity to combine their expertise and produce entirely new types of expert services. Since its inception, it has been characteristic of Medaffcon to develop new operational models by utilising its unique expertise in medical and health economic affairs.
An entire team of like-minded experts with different educational and occupational backgrounds started to rapidly aggregate around this core group. As our fields of expertise have expanded, our service supply has also become more diversified, covering more and more research and strategy services for an even wider range of customers. Today, Medaffcon employs about 30 full-time experts in different scientific disciplines.
Medaffcon is known for its strong expertise in impact assessment, and we are actively developing research based on health data and measures that can be utilised in such research. Our aim for constant improvement is also reflected in the construction of our wide-ranging cooperation network with different actors in the healthcare sector, in particular with regard to health data. Biobanks, registers and hospitals’ data pools enable entirely new kinds of studies and transform the field of impact assessment.
Medaffcon started its operation under the name of AT Medical Affairs Consulting Oy, and the pithier name Medaffcon was adopted soon after the establishment of the company. As of spring 2016, Medaffcon has been the official name of the company.
Through a corporate acquisition, Medaffcon was transferred under Tamro in May 2017, simultaneously joining the Europe-wide PHOENIX group.